| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |